Molekulardiagnostik
- PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y]Katalog Nummer: PCCSKU15266Firma:Procomcure Biotech GmbHInformation:
PHOENIXDX® SARS-COV-2 MUTANT SCREEN [N501Y] is a real-time RT-PCR-based diagnostic test for the in vitro discrimination between wildtype SARS-CoV-2 and N501Y mutant SARS-CoV-2 in respiratory specimens and sera.
- Information:
Genvinset® Lactose Intolerance is a semi-automated in vitro diagnostic kit for the qualitative detection of the polymorphisms -13910 C/T (NCBI dbSNP rs4988235; NM_005915.6: c.1917+326C>T) and -22018 G/A (NCBI dbSNP rs182549; NM_005915.5: c.1362+117G>A) of the MCM6 gene (OMIM: 601806) associated with lactase persistence, in genomic DNA extracted from whole blood, by Real Time PCR using specific TaqMan® probes technology.
- PHOENIXDX® SARS-COV-2 MUTANT SCREEN [DEL HV69/70]Katalog Nummer: PCCSKU15268Firma:Procomcure BiotechInformation:
PHOENIXDX® SARS-COV-2 MUTANT SCREEN [DEL HV69/70] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and del HV69/70 mutant SARS-CoV-2 in respiratory specimens and sera.
- PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484K]Katalog Nummer: PCCSKU15269Firma:Procomcure Biotech GmbHInformation:
PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484K] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and E484K mutant SARS-CoV-2 in respiratory specimens and sera.
- PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484Q]Katalog Nummer: PCCSKU15282Firma:Procomcure Biotech GmbHInformation:
PHOENIXDX® SARS-COV-2 MUTANT SCREEN [E484Q] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and E484Q mutant SARS-CoV-2 in respiratory specimens and sera.
- PHOENIXDX® SARS-COV-2 MUTANT SCREEN [K417N]Katalog Nummer: PCCSKU15267Firma:Procomcure Biotech GmbHInformation:
PHOENIXDX® SARS-COV-2 MUTANT SCREEN [K417N] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and K417N mutant SARS-CoV-2 in respiratory specimens and sera. The kit is intended to detect the K417N mutation in samples already tested positive for SARS-CoV-2.